✨ 𝐇𝐀𝐏𝐏𝐘 𝐍𝐄𝐖 𝐘𝐄𝐀𝐑 𝟐𝟎𝟐𝟓 ✨ As the New Year unfolds, we at Beacon Oncology Centre Klang would like to express our heartfelt gratitude to all our team, customers & patients, and the community we serve. ❤️ Here's to a year filled with health, happiness, and success for all! ✨ We will be closed tomorrow for one day in conjunction with the New Year and will resume services as usual on the 2nd of January 2025 - Thursday. Should you require further clarification or assistance, kindly drop us a message at 011-1099 6808. #BeaconOncologyCentreKlang #BOCKlang #BeaconKlang #寳康肿瘤诊所 #SeasonGreetings #HappyNewYear #HappyNewYear2025
Beacon Oncology Centre (BOC) Klang’s Post
More Relevant Posts
-
Bhargava Reddy, Chief Business Officer - Oncology at Qure.ai, will be attending the upcoming HLTH USA Conference in Las Vegas from October 20 - 23, alongside Dev Khare from Lightspeed India. They will connect and interact with industry leaders to explore innovative #healthtech developments, focusing on #AI-driven early risk detection of #lungcancer. If you’re attending and are passionate about transforming #healthcare, be sure to connect with Bhargava to discuss how we can shape the #futureofhealthtech together. #HLTHUSA #HLTHFoundation #HealthcareInnovation #AIInHealthcare #LungCancerDetection
To view or add a comment, sign in
-
-
Our portfolio company, Thymofox, is making strides in understanding how aging affects the immune system. New research from their scientific co-founders at Fred Hutch Cancer Center reveals that aging cells create “black holes” within the thymus, resembling a dense mass of dysfunctional cells that hinder T-cell production and thymus regeneration: https://lnkd.in/dajU_krT BioAge Labs is set to make its Wall Street debut, with its investor prospectus officially dropping as it prepares to trade under the ticker BIOA. The company’s lead candidate, Azelaprag, is currently in two Phase 2 trials, where it’s being tested alongside established obesity treatments from Eli Lilly and Company and Novo Nordisk: https://lnkd.in/eJNx78cX Our portfolio company YEARS recently opened a new longevity clinic in Berlin, and the interest in healthspan optimization is growing worldwide. The New York Times highlights Equinox’s new membership program, ‘Optimize by Equinox,’ coaching to help members live longer and healthier lives. With detailed blood test analysis and tailored lifestyle guidance, it’s clear that investing in health and longevity is becoming a priority: https://lnkd.in/e6U2RqqX #ICYDK #ApolloVC #Lifespan #Healthspan #Longevity #VentureCapital
To view or add a comment, sign in
-
-
✨ Microenvironment and Immunotherapy of Sarcomas Symposium 2024 ↔ M-6 Did you know that call for abstracts are currently OPENED for the 2nd Microenvironment and Immunotherapy of Sarcomas Symposium from October 10-11,2024? Here's your chance to be part of this amazing event, meet keynote speakers and share you lastest work on #sarcomaresearch! 📅 Deadline for abstract submission: Jun 30, 2024 #MIS_S2024 #RHUCONDOR #sarcoma #precisionmedicine
To view or add a comment, sign in
-
🌟 Exciting Highlight at the Upcoming Egyptian Theranostics Summit! 🌟 One of the most anticipated moments of the summit will be a powerful and inspiring session where a patient, Dr. John, will share his personal journey with Lutetium 177-PSMA therapy. He’ll discuss how the treatment positively influenced his life, not only by prolonging his survival but by significantly improving his quality of life. This session will be moderated by Dr. Yasmine Atteya, who will provide insightful commentary on the benefits of this therapy and guide us through the patient’s impactful story. Additionally, we’re thrilled to welcome Efrain Perini from Oncidium foundation to present on "How to Increase Patient Awareness and Enhance Access to Radiotheranostics Worldwide." Our patient, Dr. John Antoine, a key beneficiary of the RLT Connect Program from the foundation, will be featured as part of this discussion, showcasing how initiatives like these are transforming access to life-changing treatments. Don't miss these inspiring sessions that highlight the power of patient stories and the importance of increasing global access to cutting-edge therapies! #TheranosticsExplained #EgyptianTheranosticsSummit #PrecisionMedicine #Theranostics #NuclearMedicine #CancerCare
To view or add a comment, sign in
-
-
Be an advocate for Black representation in multiple myeloma research! 🧭🗺️ Discover if you or a loved one could be eligible for a clinical trial. Start your journey with a quick pre-screener: https://bit.ly/4eErk0V #multiplemyeloma #myeloma #myelomawarrior #myelomaawareness #cancerjourney
To view or add a comment, sign in
-
-
So your organization has successfully established a cardio-oncology program – now what? Join us virtually in two weeks when we'll answer that question and discuss common growing pains. Save your spot: https://lnkd.in/eGYxzx3A #cardioonc #cardiooncology #cardioncologia #centerofexcellence
To view or add a comment, sign in
-
-
#Clinicaltrial sites are juggling more than ever before due to the increase in protocol complexity. By simplifying and automating participant payments, sites can free up valuable time to focus on what truly matters – advancing research and caring for participants. In our latest Trailblazer webinar, Amy Avergas MSIT, MBA, Manager of Oncology Research at Medstar Health Research Institute, shared her insights on how Greenphire's ClinCard is revolutionizing participant payments for both patients and research sites. Watch now to see how ClinCard is making a difference!
To view or add a comment, sign in
-
Keep up with the newest developments in #PrecisionMedicine! LARVOL curates top news, carefully assessed for uniqueness, relevance, and impact by our industry experts. Schedule your demo today 👉 bit.ly/3goXLHE #PrecisionOncology #CancerResearch #LARVOL
To view or add a comment, sign in
-
Keep up with the newest developments in #PrecisionMedicine! LARVOL curates top news, carefully assessed for uniqueness, relevance, and impact by our industry experts. Schedule your demo today 👉 bit.ly/3goXLHE #PrecisionOncology #CancerResearch #LARVOL
To view or add a comment, sign in
-
Keep up with the newest developments in #PrecisionMedicine! LARVOL curates top news, carefully assessed for uniqueness, relevance, and impact by our industry experts. Schedule your demo today 👉 bit.ly/3goXLHE #PrecisionOncology #CancerResearch #LARVOL
To view or add a comment, sign in